Grace Therapeutics (GRCE) Stock Price, News & Analysis

Company Overview

Grace Therapeutics Inc. is a late-stage biopharma company advancing GTx-104, its novel injectable formulation of nimodipine which addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage. Grace Therapeutics Inc., formerly known as Acasti Pharma Inc., is based in Princeton, New Jersey.

Key Stats

• Today's Range: $3.65 to $3.94
• 50-Day Range: N/A
• 52-Week Range: $1.98 to $4.97
• Volume: 19,432 shs
• Average Volume: 27,675 shs
• Market Capitalization: $39.04 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GRCE Stock Analysis - Frequently Asked Questions

How have GRCE shares performed this year?

Grace Therapeutics' stock was trading at $3.37 at the beginning of 2024. Since then, GRCE shares have increased by 9.2% and is now trading at $3.68.
View the best growth stocks for 2024 here.

How do I buy shares of Grace Therapeutics?

Shares of GRCE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 12/18/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:GRCE
• CUSIP: N/A
• CIK: 1444192
• Web: www.acastipharma.com
• Phone: 818-839-4378
• Fax: 45-0687-2272
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-12,850,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -18.09%
• Return on Assets: -15.38%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.01
• Quick Ratio: 6.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $6.57 per share
• Price / Book: 0.58

Miscellaneous

• Outstanding Shares: 10,140,000
• Free Float: 8,770,000
• Market Cap: $38.53 million
• Optionable: N/A
• Beta: 1.49